Colorado Springs Health Collective
Hyperbaric Clinic — Opening Fall 2026
Clinical Grade
2.0 ATAHyperbaric Oxygen Therapy Colorado Springs — 2.0 ATA HBOT for Fibromyalgia, Long COVID, Wound Healing & Anti-Aging
Coming Fall 2026 — Lock In Your 25% Discount Today.
Most local providers operate at 1.3–1.6 ATA. We're opening a clinical-grade chamber at 2.0 ATA — the pressure the clinical evidence was built on.
The Science
At 2.0 ATA, your body unlocks capabilities it can't access normally.
Oxygen dissolves directly into plasma — reaching 10–15× normal levels in tissue standard circulation can't supply. What follows is a cascade of healing your body was always designed to do.
Angiogenesis — formation of new blood vessels — restores circulation to tissue that was too damaged or irradiated to heal on its own.
Up to 8× more stem cells released from bone marrow into circulation — traveling to sites of injury to rebuild damaged tissue.
Pro-inflammatory cytokines (TNF-α, IL-6) measurably reduced. The chronic inflammatory cascade driving autoimmune disease, pain, and aging — interrupted.
1,912 differentially expressed genes after a full HBOT course — aging-associated pathways downregulated, regenerative pathways activated.
The 2.0 ATA Difference
Pressure is the therapy. Most chambers don't have enough of it.
The landmark trials — fibromyalgia, Long COVID, stroke, anti-aging — were run at 2.0 ATA. Soft-shell "mild HBOT" chambers at 1.3–1.6 ATA simply cannot reproduce those oxygen levels. If the pressure is different, it's a different treatment.
What We Treat
One therapy. Extraordinary reach.
Wound Healing & Surgical Recovery
Post-mastectomy. Aesthetic surgery. Abdominal wounds. HBOT is FDA-approved for compromised tissue repair — delivering oxygenation that no other therapy can reach.
Anti-Aging & Longevity
37% fewer senescent cells. 20%+ telomere lengthening. Real reversal of cellular aging — measured in human trials, not animals.
Autoimmune & Inflammation
Systemic reduction of TNF-α and IL-6 — the inflammatory drivers behind UC, RA, psoriasis, and chronic disease. 50% clinical remission in a blinded UC trial vs. 0% in the control group.
Muscle, Tendon & Athletic Recovery
Accelerate biological repair of damaged muscle and connective tissue. Higher training density. Lower injury risk. Confirmed in a 2026 meta-analysis of 10 RCTs.
Chronic Pain & Fibromyalgia
Beat fibromyalgia medications head-to-head in a randomized trial. HBOT modifies the neurological root of pain — not just the symptoms. 87.5–100% pain relief rates documented.
Long COVID Recovery
Microvascular damage. Neuroinflammation. Mitochondrial dysfunction. HBOT addresses all three — with durable improvements confirmed at 1-year follow-up.
Brain & Neurological Recovery
Reactivate dormant neurons after stroke. Improve TBI-related deficits years — even decades — after injury. Documented with SPECT and fNIRS brain imaging in clinical trials.
Sudden Hearing Loss
Guideline-endorsed. 2.61× higher recovery rate. Time is everything — the sooner you start, the better the outcome.
Our Philosophy
We show you the real research.
Fourteen conditions. Four tiers of evidence. Honest clinical perspective on every one — including what the studies show and where the science is still building. Because informed patients make the best decisions.
View the Evidence
Limited Pre-Launch Spots
Be first. Save 25%.
No commitment required. No payment. Register and we'll contact you when we open with your discount locked in.
Questions? Call or text 719-824-4716